• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于东欧国家初级保健中心力衰竭筛查的N末端B型利钠肽原:我们所了解的情况及建议措施

NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps.

作者信息

Teleanu Ioana Camelia, Mîrșu-Păun Anca, Bejan Cristian Gabriel, Stănescu Ana-Maria Alexandra

机构信息

Department of Family Medicine, "Carol Davila" University of Medicine and Pharmacy, 030167 Bucharest, Romania.

出版信息

Epidemiologia (Basel). 2025 Jan 15;6(1):2. doi: 10.3390/epidemiologia6010002.

DOI:10.3390/epidemiologia6010002
PMID:39846532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11755574/
Abstract

Epidemiological studies indicate that heart failure (HF) prevalence and associated mortality are significantly higher among Eastern European countries as compared to their Western European counterparts. The significant financial burden on the healthcare system matches these sobering data. Thus, efficient programs for patients with HF have been called for. N-terminal prohormone of brain natriuretic peptide (NT-proBNP) represents a widely used, cost-effective, and readily available test that can be used to evaluate HF risk. However, it should not be used as a universal assessment, given the existing variability in proposed cut-off scores for various subgroups of patients. Thus, the clinical context needs to always be considered, and alternative diagnoses need to be ruled out. Based upon evidence from the literature for the above assumptions, the advantages and limitations of using NT-proBNP in primary care settings, along with other HF diagnostic modalities, are discussed in this paper. Also, this paper argues that an effective primary care network, in collaboration with specialist providers, may avoid a delay in HF diagnoses, may help provide on-time treatments, and may ultimately cut unnecessary healthcare expenditures associated with HF hospitalizations. Therefore, the present paper proposes an algorithm for diagnosing HF in primary care settings and discusses specific knowledge and skills that family physicians should be well equipped with in order to successfully respond to the needs of their patients with HF.

摘要

流行病学研究表明,与西欧国家相比,东欧国家的心力衰竭(HF)患病率及相关死亡率显著更高。医疗系统面临的巨大经济负担与这些严峻的数据相符。因此,人们呼吁为心力衰竭患者制定有效的方案。脑钠肽前体N端(NT-proBNP)是一种广泛应用、经济高效且易于获取的检测指标,可用于评估心力衰竭风险。然而,鉴于针对不同患者亚组提出的临界值存在差异,不应将其用作通用评估方法。因此,始终需要考虑临床背景,并排除其他诊断。基于上述假设的文献证据,本文讨论了在基层医疗环境中使用NT-proBNP以及其他心力衰竭诊断方法的优缺点。此外,本文认为,有效的基层医疗网络与专科医疗服务提供者合作,可避免心力衰竭诊断延误,有助于及时提供治疗,并最终减少与心力衰竭住院相关的不必要医疗支出。因此,本文提出了一种在基层医疗环境中诊断心力衰竭的算法,并讨论了家庭医生为成功满足心力衰竭患者需求应具备的特定知识和技能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10d/11755574/27e24597dfd3/epidemiologia-06-00002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10d/11755574/27e24597dfd3/epidemiologia-06-00002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10d/11755574/27e24597dfd3/epidemiologia-06-00002-g001.jpg

相似文献

1
NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps.用于东欧国家初级保健中心力衰竭筛查的N末端B型利钠肽原:我们所了解的情况及建议措施
Epidemiologia (Basel). 2025 Jan 15;6(1):2. doi: 10.3390/epidemiologia6010002.
2
Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.B 型利钠肽(BNP)和氨基末端 B 型利钠肽前体(NT-proBNP)在疑似心力衰竭成人中的诊断检测作用:卫生技术评估。
Ont Health Technol Assess Ser. 2021 May 6;21(2):1-125. eCollection 2021.
3
Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.在基层医疗中排除心力衰竭:使用N末端B型利钠肽原(NT-proBNP)和QRS波宽度进行预筛查的成本效益
Int J Cardiol. 2008 Nov 28;130(3):426-37. doi: 10.1016/j.ijcard.2007.08.131. Epub 2008 Feb 21.
4
Cost-effectiveness of NT-proBNP-supported screening of chronic heart failure in patients with or without type 2 diabetes in Austria and Switzerland.在奥地利和瑞士,NT-proBNP支持的2型糖尿病患者或非2型糖尿病患者慢性心力衰竭筛查的成本效益。
J Med Econ. 2023 Jan-Dec;26(1):1287-1300. doi: 10.1080/13696998.2023.2264722. Epub 2023 Oct 18.
5
[Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].[目前使用的标准及脑钠肽对先天性心脏病患儿充血性心力衰竭的诊断价值]
Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):728-32.
6
Diagnostic properties of natriuretic peptides and opportunities for personalized thresholds for detecting heart failure in primary care.利钠肽的诊断特性和在初级保健中检测心力衰竭的个性化阈值的机会。
Diagnosis (Berl). 2023 Sep 5;10(4):432-439. doi: 10.1515/dx-2023-0089. eCollection 2023 Nov 1.
7
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.利钠肽指导治疗对射血分数降低的高危心力衰竭患者住院率或心血管死亡率的影响:一项随机临床试验。
JAMA. 2017 Aug 22;318(8):713-720. doi: 10.1001/jama.2017.10565.
8
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction.沙库巴曲缬沙坦对射血分数保留的心力衰竭患者氨基末端 B 型利钠肽前体的影响。
JACC Heart Fail. 2020 May;8(5):372-381. doi: 10.1016/j.jchf.2020.03.002. Epub 2020 Mar 30.
9
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.N端前B型利钠肽水平在伴或不伴心房颤动的心力衰竭患者中的预后价值
Circ Heart Fail. 2017 Oct;10(10). doi: 10.1161/CIRCHEARTFAILURE.117.004409.
10
Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges.利钠肽家族作为成人及老年心力衰竭患者管理中的诊断/预后生物标志物及治疗方式:尚存问题与挑战
J Geriatr Cardiol. 2018 Aug;15(8):540-546. doi: 10.11909/j.issn.1671-5411.2018.08.008.

引用本文的文献

1
Predicting Quality of Life of Patients in Romania with Heart Failure with Preserved Ejection Fraction by Analyzing H2FPEF Scores.通过分析H2FPEF评分预测罗马尼亚射血分数保留的心力衰竭患者的生活质量
Healthcare (Basel). 2025 Apr 15;13(8):909. doi: 10.3390/healthcare13080909.
2
Identification of Metabolism-Related Hub Genes in Heart Failure via Comprehensive Transcriptome Analysis.通过综合转录组分析鉴定心力衰竭中与代谢相关的枢纽基因
Genes (Basel). 2025 Mar 3;16(3):305. doi: 10.3390/genes16030305.

本文引用的文献

1
Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement.中东欧和波罗的海地区的心力衰竭护理:现状、障碍和改善途径。
ESC Heart Fail. 2024 Aug;11(4):1861-1874. doi: 10.1002/ehf2.14687. Epub 2024 Mar 22.
2
Biomarkers for Heart Failure Prediction and Prevention.用于心力衰竭预测与预防的生物标志物
J Cardiovasc Dev Dis. 2023 Dec 6;10(12):488. doi: 10.3390/jcdd10120488.
3
Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies.心力衰竭管理的进展:新兴疗法的全面叙述性综述
Cureus. 2023 Oct 4;15(10):e46486. doi: 10.7759/cureus.46486. eCollection 2023 Oct.
4
Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC.使用N末端B型利钠肽原(NT-proBNP)进行心力衰竭和心脏应激早期诊断的实用算法:欧洲心脏病学会心力衰竭协会的临床共识声明
Eur J Heart Fail. 2023 Nov;25(11):1891-1898. doi: 10.1002/ejhf.3036. Epub 2023 Sep 26.
5
Levels of NT‑proBNP in patients with cancer.癌症患者的N末端B型利钠肽原(NT-proBNP)水平。
Oncol Lett. 2023 May 16;26(1):280. doi: 10.3892/ol.2023.13866. eCollection 2023 Jul.
6
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society.糖尿病患者心力衰竭诊断的生物标志物:糖尿病技术协会共识报告
Prog Cardiovasc Dis. 2023 Jul-Aug;79:65-79. doi: 10.1016/j.pcad.2023.05.002. Epub 2023 May 11.
7
The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients.脑钠肽在老年心力衰竭评估中的应用
Diagnostics (Basel). 2023 Apr 23;13(9):1512. doi: 10.3390/diagnostics13091512.
8
Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort.大型普通人群队列中 NT-proBNP(N 端脑利钠肽前体)的参考范围和 NT-proBNP 浓度升高的危险因素。
Circ Heart Fail. 2022 Oct;15(10):e009427. doi: 10.1161/CIRCHEARTFAILURE.121.009427. Epub 2022 Sep 13.
9
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南。
J Card Fail. 2022 May;28(5):e1-e167. doi: 10.1016/j.cardfail.2022.02.010. Epub 2022 Apr 1.
10
Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality.利钠肽水平正常的射血分数保留的心力衰竭患者的发病率和死亡率增加。
Eur Heart J. 2022 May 21;43(20):1941-1951. doi: 10.1093/eurheartj/ehab911.